Bradley Lawrence Freilich MD FAASLD,AGAF, CCI
Advanced Endoscopic Interventional, Hepatology & Liver Transplantation, Inflammatory Bowel Disease, Bariatric Medicine
Partner Kansas City Gastroenterology Director Liver and Pancreas Institute of Kansas City Director Kansas City Research Institute Director HCA Metabolic Syndrome/Weight Loss Center
Join to view full profile
6675 Holmes Rd Ste 430Kansas City, MO 64131
Phone+1 816-361-0055
Fax+1 816-552-5899
Dr. Freilich is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bradley Freilich is a gastroenterologist based in Kansas City, MO, specializing in advanced endoscopic interventional procedures, hepatology and liver transplantation, inflammatory bowel disease, and bariatric medicine. He completed his fellowship in gastroenterology at UCLA and his residency in internal medicine at Rush University Medical Center. Since 1998, he has been a physician and founding partner at both Research Medical Center and Menorah Medical Center, as well as KCGI. His clinical expertise includes ulcerative colitis, Crohn's disease, and various liver conditions, and he has contributed to notable publications on non-alcoholic steatohepatitis and other liver diseases, which have been widely cited. Dr. Freilich has been involved in multiple clinical trials, focusing on NASH, hepatocellular carcinoma, diabetic gastroparesis, and hepatitis C. He holds honors such as CMS Meaningful Use Stage 1 Certification and is a Fellow of the American Gastroenterological Association.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1991 - 1994
Rush University Medical CenterResidency, Internal Medicine, 1988 - 1991
University of Missouri Kansas City School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1991 - Present
KS State Medical License 1994 - 2027
MO State Medical License 1994 - 2027
American Board of Internal Medicine Gastroenterology
American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification eClinicalWorks, eClinicalWorks, LLC, 2013-2014
- CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012-2013
- Fellow (AGAF) American Gastroenterological Association, 2006
Clinical Trials
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis
- Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing
Publications & Presentations
PubMed
- A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.Mary E Rinella, Hsiao D Lieu, Kris V Kowdley, Zachary D Goodman, Naim Alkhouri
Hepatology. 2024-03-01 - 88 citationsA randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis.Stephen A Harrison, Peter J Ruane, Bradley Freilich, Guy Neff, Rashmee Patil
JHEP Reports. 2023-01-01 - 94 citationsAldafermin in patients with non-alcoholic steatohepatitis (ALPINE 2/3): a randomised, double-blind, placebo-controlled, phase 2b trial.Stephen A Harrison, Manal F Abdelmalek, Guy Neff, Nadege Gunn, Cynthia D Guy
The Lancet. Gastroenterology & Hepatology. 2022-07-01
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: